Historical overview of the interleukin-6 family cytokine
Open accessThe DOI matches its Crossref record; 103 of the 105 references it cites were found in a registry or an index.
Abstract
Interleukin-6 (IL-6) has been identified as a 26-kD secreted protein that stimulates B cells to produce antibodies. Later, IL-6 was revealed to have various functions that overlap with other IL-6 family cytokines and use the common IL-6 signal transducer gp130. IL-6 stimulates cells through multiple pathways, using both membrane and soluble IL-6 receptors. As indicated by the expanding market for IL-6 inhibitors, it has become a primary therapeutic target among IL-6 family cytokines. Here, we revisit the discovery of IL-6; discuss insights regarding the roles of this family of cytokines; and highlight recent advances in our understanding of regulation of IL-6 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Receptor composition of IL-6 family cytokines. IL-6 family cytokines use gp130 to transduce their signals through gp130 homodimers or gp130-containing heterodimers. IL-6, IL-11, CNTF, CLCF1, and CLCF1/CLF require binding of their nonsignaling receptor to transduce signals. A new group of members (IL-27, IL-35, and IL-39) are heterodimeric cytokines: IL-27 consists of IL-27/p28 (IL-27α) and EBI3 (also known as IL-27β); in conformity to IL-12 containing IL-12p40 (IL-12α) and IL-12p35 (IL-12β), IL-23 (IL-23p19 [IL-23α] and IL-23p40 [IL-23β]), IL-35 (IL-23p40 and EBI3), and IL-39 (IL-23p19 and EBI3; Hunter, 2005; Ning-Wei, 2010; Wang et al., 2016a). These new members activate heterodimers of gp130. IL-6R exerts its biological effects via three different signaling modes. IL-6R expression is restricted to hepatocytes and several types of immune cells, whereas gp130 is ubiquitously expressed, reflecting the diverse roles of IL-6. In the classical mode of IL-6 signaling, the cytokine interacts with mIL-6R in cells that also express gp130 (Hunter and Jones, 2015). IL-6 also binds soluble IL-6R (sIL-6R), which is shed from cells following cleavage by ADAM metalloprotease 17 (ADAM17), and is also created by alternative mRNA splicing (Lust et al., 1992). The IL-6–sIL-6R complex binds to gp130, forming a dimer that initiates intracellular signaling, a process referred to as trans-signaling. Recently, a third mode of IL-6 signaling was identified: IL-6 trans-presentation (Heink et al., 2017). This mode is specific to dendritic cells, in which the IL-6–mIL-6R complex is presented to gp130 expressed on T cells to prime pathogenic Th17 cells. These alternative modes of IL-6 signaling contribute to multiple cellular processes.](https://figures.cochat.ai/paper-figures/0d0052256f4b4b9dbf5a3cb45efbedda/historical-overview-of-the-interleukin-6-family-cytokine-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increased Tag+ T cell effector responses in sgBaat were also accompanied by an increase in both CD4+ T cells and natural killer cells and elevated proinflammatory cytokines [interleukin-12 (IL-12), tumor necrosis factor (TNF), IFN-γ, IL-15, IL-7] and decreased tumor-promoting cytokines such as IL-6, leukemia inhibitory factor, and IL-11 within the liver microenvironment (Fig. 2D and figs. S3,”
From Bile acid synthesis impedes tumor-specific T cell responses during liver cancer (2025) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Self-citationKishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Self-citationStructural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00324-2 · Cited by 1,462
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Self-citation(2012) · The Lancet · doi:10.1016/s0140-6736(12)60110-x · Cited by 1,146
Stress granules: the Tao of RNA triage
Anderson, P., & Kedersha, N. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.003 · Cited by 1,116
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J.-C., Tedgui, A., Haegeman, G., & Staels, B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32048 · Cited by 1,089
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T., & Kishimoto, T. (1988) · Science · doi:10.1126/science.3136546 · Cited by 1,060
Self-citationMolecular cloning and expression of an IL-6 signal transducer, gp130
Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., & Kishimoto, T. (1990) · Cell · doi:10.1016/0092-8674(90)90411-7 · Cited by 1,039
Self-citationStahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E., & Yancopoulos, G. D. (1995) · Science · doi:10.1126/science.7871433 · Cited by 979
Historical insights into cytokines
Dinarello, C. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737772 · Cited by 926 · cited 1×
“Most cytokines associate with specific receptors, through which they transmit intercellular signals to their target cells (Dinarello, 2007).”
BackgroundTargeting Interleukin-6 Signaling in Clinic
Kang, S., Tanaka, T., Narazaki, M., & Kishimoto, T. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.026 · Cited by 904
Self-citationNew IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
Hunter, C. A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1648 · Cited by 852
(2012) · The Lancet · doi:10.1016/s0140-6736(11)61931-4 · Cited by 823
Lütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., et al. (1994) · Science · doi:10.1126/science.8272872 · Cited by 814
Self-citationInterleukin-6 Family Cytokines
Rose-John, S. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028415 · Cited by 799
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Self-citationPaul, S. R., Bennett, F., Calvetti, J. A., Kelleher, K., Wood, C. R., O'Hara, R. M., Leary, A. C., Sibley, B., Clark, S. C., & Williams, D. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7512 · Cited by 652
Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay
Matsushita, K., Takeuchi, O., Standley, D. M., Kumagai, Y., Kawagoe, T., Miyake, T., Satoh, T., Kato, H., Tsujimura, T., Nakamura, H., et al. (2009) · Nature · doi:10.1038/nature07924 · Cited by 649
Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex
Boulanger, M. J., Chow, D.-C., Brevnova, E. E., & Garcia, K. C. (2003) · Science · doi:10.1126/science.1083901 · Cited by 642
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Haemopoietic receptors and helical cytokines
Bazan, J. F. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90139-z · Cited by 638
Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.407 · Cited by 635
Self-citationA gp130–Src–YAP module links inflammation to epithelial regeneration
Taniguchi, K., Wu, L.-W., Grivennikov, S. I., de Jong, P. R., Lian, I., Yu, F.-X., Wang, K., Ho, S. B., Boland, B. S., Chang, J. T., et al. (2015) · Nature · doi:10.1038/nature14228 · Cited by 633
Niedbala, W., Wei, X., Cai, B., Hueber, A. J., Leung, B. P., McInnes, I. B., & Liew, F. Y. (2007) · European Journal of Immunology · doi:10.1002/eji.200737810 · Cited by 588
Gearing, D. P., Gough, N. M., King, J. A., Hilton, D. J., Nicola, N. A., Simpson, R. J., Nice, E. C., Kelso, A., & Metcalf, D. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02742.x · Cited by 574
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.
Pennica, D., King, K. L., Shaw, K. J., Luis, E., Rullamas, J., Luoh, S. M., Darbonne, W. C., Knutzon, D. S., Yen, R., & Chien, K. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1142 · Cited by 554
Zilberstein, A., Ruggieri, R., Korn, J. H., & Revel, M. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04531.x · Cited by 487
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477
The composition and signaling of the IL-35 receptor are unconventional
Collison, L. W., Delgoffe, G. M., Guy, C. S., Vignali, K. M., Chaturvedi, V., Fairweather, D., Satoskar, A. R., Garcia, K. C., Hunter, C. A., Drake, C. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2227 · Cited by 450
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
Klein, B., Wijdenes, J., Zhang, X., Jourdan, M., Boiron, J., Brochier, J., Liautard, J., Merlin, M., Clement, C., & Morel-Fournier, B. (1991) · Blood · doi:10.1182/blood.v78.5.1198.1198 · Cited by 418
Purification, Cloning, and Expression of Ciliary Neurotrophic Factor (CNTF)
Lin, L.-F. H., Mismer, D., Lile, J. D., Armes, L. G., Butler, E. T., Vannice, J. L., & Collins, F. (1989) · Science · doi:10.1126/science.2587985 · Cited by 417
Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses
Kimura, A., Naka, T., Nakahama, T., Chinen, I., Masuda, K., Nohara, K., Fujii-Kuriyama, Y., & Kishimoto, T. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090560 · Cited by 412
Self-citationIL-6 and NF-IL6 in acute-phase response and viral infection
Akira, S., & Kishimoto†, T. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01407.x · Cited by 411
Self-citationMino, T., Murakawa, Y., Fukao, A., Vandenbon, A., Wessels, H.-H., Ori, D., Uehata, T., Tartey, S., Akira, S., Suzuki, Y., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.029 · Cited by 390
Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
Heink, S., Yogev, N., Garbers, C., Herwerth, M., Aly, L., Gasperi, C., Husterer, V., Croxford, A. L., Möller-Hackbarth, K., Bartsch, H. S., et al. (2017) · Nature Immunology · doi:10.1038/ni.3632 · Cited by 386
Organizing Principles of Mammalian Nonsense-Mediated mRNA Decay
Popp, M. W.-L., & Maquat, L. E. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-111212-133424 · Cited by 372
Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins
Mackiewicz, A., Schooltink, H., Heinrich, P. C., & Rose-John, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2021 · Cited by 370
Hirano, T., Taga, T., Yasukawa, K., Nakajima, K., Nakano, N., Takatsuki, F., Shimizu, M., Murashima, A., Tsunasawa, S., & Sakiyama, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.228 · Cited by 351
Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation
Uehata, T., Iwasaki, H., Vandenbon, A., Matsushita, K., Hernandez-Cuellar, E., Kuniyoshi, K., Satoh, T., Mino, T., Suzuki, Y., Standley, D. M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.034 · Cited by 349
Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.1120 · Cited by 343
Self-citationStructural analysis of the sequence coding for an inducible 26‐kDa protein in human fibroblasts
HAEGEMAN, G., CONTENT, J., VOLCKAERT, G., DERYNCK, R., TAVERNIER, J., & FIERS, W. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09931.x · Cited by 337
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Zcchc11-dependent uridylation of microRNA directs cytokine expression
Jones, M. R., Quinton, L. J., Blahna, M. T., Neilson, J. R., Fu, S., Ivanov, A. R., Wolf, D. A., & Mizgerd, J. P. (2009) · Nature Cell Biology · doi:10.1038/ncb1931 · Cited by 300
Iwasaki, H., Takeuchi, O., Teraguchi, S., Matsushita, K., Uehata, T., Kuniyoshi, K., Satoh, T., Saitoh, T., Matsushita, M., Standley, D. M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2137 · Cited by 288
The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.
Müllberg, J., Oberthür, W., Lottspeich, F., Mehl, E., Dittrich, E., Graeve, L., Heinrich, P. C., & Rose-John, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.4958 · Cited by 269
Post-transcriptional regulons coordinate the initiation and resolution of inflammation
Anderson, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2685 · Cited by 257
Genome-wide Analysis Identifies Interleukin-10 mRNA as Target of Tristetraprolin
Stoecklin, G., Tenenbaum, S. A., Mayo, T., Chittur, S. V., George, A. D., Baroni, T. E., Blackshear, P. J., & Anderson, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709657200 · Cited by 238
Regulation of IL-6 in Immunity and Diseases
Tanaka, T., Narazaki, M., Masuda, K., & Kishimoto, T. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-024-0921-5_4 · Cited by 235
Self-citationIL-6-regulated transcription factors
Akira, S. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00063-0 · Cited by 233
Wilsker, D. F., Patsialou, A., Dallas, P. B., & Morán, E. (2002) · PubMed · Cited by 229
Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo
Masuda, K., Ripley, B., Nishimura, R., Mino, T., Takeuchi, O., Shioi, G., Kiyonari, H., & Kishimoto, T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307419110 · Cited by 226
Self-citationBetz, U. A. K., Bloch, W., van den Broek, M., Yoshida, K., Taga, T., Kishimoto, T., Addicks, K., Rajewsky, K., & Müller, W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1955 · Cited by 218
Self-citationSpencer, S., Köstel Bal, S., Egner, W., Lango Allen, H., Raza, S. I., Ma, C. A., Gürel, M., Zhang, Y., Sun, G., Sabroe, R. A., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190344 · Cited by 205
Schwerd, T., Twigg, S. R. F., Aschenbrenner, D., Manrique, S., Miller, K. A., Taylor, I. B., Capitani, M., McGowan, S. J., Sweeney, E., Weber, A., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161810 · Cited by 201
The Two-Faced Cytokine IL-6 in Host Defense and Diseases
Narazaki, M., & Kishimoto, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113528 · Cited by 201
Self-citationHe, M., Xu, Z., Ding, T., Kuang, D.-M., & Zheng, L. (2009) · Cellular & Molecular Immunology · doi:10.1038/cmi.2009.45 · Cited by 198
Malik, N., Kallestad, J. C., Gunderson, N. L., Austin, S. D., Neubauer, M. G., Ochs, V, Marquardt, H., Zarling, J. M., Shoyab, M., & Wei, C. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.2847 · Cited by 197
TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a
Nyati, K. K., Masuda, K., Zaman, M. M.-U., Dubey, P. K., Millrine, D., Chalise, J. P., Higa, M., Li, S., Standley, D. M., Saito, K., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx064 · Cited by 190
Self-citationLiu, J., Guan, X., & Ma, X. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061440 · Cited by 188
A role for IL-27p28 as an antagonist of gp130-mediated signaling
Stumhofer, J. S., Tait, E. D., III, W. J. Q., Hosken, N., Spudy, B., Goenka, R., Fielding, C. A., O'Hara, A. C., Chen, Y., Jones, M. L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1957 · Cited by 184
KOJ, A. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb23994.x · Cited by 177
A novel IL‐23p19/Ebi3 (IL‐39) cytokine mediates inflammation in Lupus‐like mice
Wang, X., Wei, Y., Xiao, H., Liu, X., Zhang, Y., Han, G., Chen, G., Hou, C., Ma, N., Shen, B., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546095 · Cited by 175
Barkhausen, T., Tschernig, T., Rosenstiel, P., van Griensven, M., Vonberg, R.-P., Dorsch, M., Mueller-Heine, A., Chalaris, A., Scheller, J., Rose-John, S., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318211ff56 · Cited by 169
Constitutive production of interleukin‐6 and immunologic features in cardiac myxomas
Jourdan, M., Bataille, R., Seguin, J., Zhang, X. G., Chaptal, P. A., & Klein, B. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330313 · Cited by 168
A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
Tanaka, T., Narazaki, M., Ogata, A., & Kishimoto, T. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.009 · Cited by 164
Self-citationHirahara, K., Onodera, A., Villarino, A. V., Bonelli, M., Sciumè, G., Laurence, A., Sun, H.-W., Brooks, S. R., Vahedi, G., Shih, H.-Y., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.014 · Cited by 155
Multiple Sklerose: Neu entdeckter Signalmechanismus macht T-Zellen pathogen
(2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0042-123476 · Cited by 155
Regulation of the acute phase and immune responses: interleukin-6.
Sehgal, P. B. (1989) · PubMed · Cited by 148
Hasegawa, H., Mizoguchi, I., Chiba, Y., Ohashi, M., Xu, M., & Yoshimoto, T. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00479 · Cited by 142
Layton, M. J., Cross, B. A., Metcalf, D., Ward, L. D., Simpson, R. J., & Nicola, N. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8616 · Cited by 140
Signaling of Human Ciliary Neurotrophic Factor (CNTF) Revisited
Schuster, B., Kovaleva, M., Sun, Y., Regenhard, P., Matthews, V., Grötzinger, J., Rose-John, S., & Kallen, K.-J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210044200 · Cited by 138
Nakahama, T., Kimura, A., Nguyen, N. T., Chinen, I., Hanieh, H., Nohara, K., Fujii-Kuriyama, Y., & Kishimoto, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111786108 · Cited by 132
Self-citationAlveolar Epithelial STAT3, IL-6 Family Cytokines, and Host Defense during Escherichia coli Pneumonia
Quinton, L. J., Jones, M. R., Robson, B. E., Simms, B. T., Whitsett, J. A., & Mizgerd, J. P. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0365oc · Cited by 118
Interleukin-11 Signals through the Formation of a Hexameric Receptor Complex
Barton, V. A., Hall, M. A., Hudson, K., & Heath, J. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004648200 · Cited by 115
MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1
Chen, C. A., Chang, J. T., Ho, Y.-F., & Shyu, A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw205 · Cited by 114
Zhao, W., Liu, M., D'Silva, N. J., & Kirkwood, K. L. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0154 · Cited by 106
Lu, Z. Y., Brochier, J., Wijdenes, J., Brailly, H., Bataille, R., & Klein, B. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221110 · Cited by 102
Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA
Masuda, K., Ripley, B., Nyati, K. K., Dubey, P. K., Zaman, M. M.-U., Hanieh, H., Higa, M., Yamashita, K., Standley, D. M., Mashima, T., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151289 · Cited by 88
Self-citationKeupp, K., Li, Y., Vargel, I., Hoischen, A., Richardson, R., Neveling, K., Alanay, Y., Uz, E., Elcioğlu, N., Rachwalski, M., et al. (2013) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.28 · Cited by 77
Post-transcriptional regulation of immune responses by RNA binding proteins
Mino, T., & Takeuchi, O. (2018) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.94.017 · Cited by 77
Amatya, N., Childs, E. E., Cruz, J. A., Aggor, F. E. Y., Garg, A. V., Berman, A. J., Gudjonsson, J. E., Atasoy, U., & Gaffen, S. L. (2018) · Science Signaling · doi:10.1126/scisignal.aat4617 · Cited by 75
Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma–associated herpesvirus
Aoki, Y., Narazaki, M., Kishimoto, T., & Tosato, G. (2001) · Blood · doi:10.1182/blood.v98.10.3042 · Cited by 74
Self-citationWang, X., Liu, X., Zhang, Y., Wang, Z., Zhu, G., Han, G., Chen, G., Hou, C., Wang, T., Ma, N., et al. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12840 · Cited by 64
Higa, M., Oka, M., Fujihara, Y., Masuda, K., Yoneda, Y., & Kishimoto, T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719921115 · Cited by 61
Self-citationArid5a exacerbates IFN-γ-mediated septic shock by stabilizing T-bet mRNA
Zaman, M. M.-U., Masuda, K., Nyati, K. K., Dubey, P. K., Ripley, B., Wang, K., Chalise, J. P., Higa, M., Hanieh, H., & Kishimoto, T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613307113 · Cited by 56
Self-citationCui, X., Mino, T., Yoshinaga, M., Nakatsuka, Y., Hia, F., Yamasoba, D., Tsujimura, T., Tomonaga, K., Suzuki, Y., Uehata, T., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701211 · Cited by 52
ELISA Detection of Circulating Levels of LIF, OSM, and CNTF in Septic Shock
Guillet, C., Fourcin, M., Chevalier, S., POUPLARD, A., & Gascan, H. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32349.x · Cited by 48
Kishimoto, T., & Ishizaka, K. (1976) · PubMed · Cited by 44
Self-citationCloning and characterization of human oncostatin M promoter
Ma, Y. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.23.4649 · Cited by 43
Vlotides, G., Zitzmann, K., Stalla, G. K., & Auernhammer, C. J. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.04.002 · Cited by 43
Regulation of Antibody Response in Vitro
Kishimoto, T., & Ishizaka, K. (1976) · The Journal of Immunology · doi:10.4049/jimmunol.116.2.534 · Cited by 41
Self-citationA Soluble Form of IL-27Rα Is a Natural IL-27 Antagonist
Dietrich, C., Candon, S., Ruemmele, F. M., & Devergne, O. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303435 · Cited by 37
Song, Q., Li, H., Shao, H., Li, C., & Lü, X. (2015) · PubMed · Cited by 34
Post‐transcriptional control of immune responses and its potential application
Yoshinaga, M., & Takeuchi, O. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1063 · Cited by 33
Zhang, X., Wu, H., Dobson, J. R., Browne, G., Hong, D., Akech, J., Languino, L. R., Stein, G. S., & Lian, J. B. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25167 · Cited by 31
Interleukin (IL)-35 is raising our expectations
Zhao, N. (2010) · Revista médica de Chile · doi:10.4067/s0034-98872010000600015 · Cited by 22
Cited by
COVID-19 is, in the end, an endothelial disease
Libby, P., & Lüscher, T. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa623 · Cited by 961
Targeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms
Kang, S., & Kishimoto, T. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00649-0 · Cited by 375
Self-citationInterleukin-6 in Rheumatoid Arthritis
Pandolfi, F., Franza, L., Carusi, V., Altamura, S., Andriollo, G., & Nucera, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155238 · Cited by 278
Baldini, C., Moriconi, F. R., Galimberti, S., Libby, P., & De Caterina, R. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab447 · Cited by 167
Metadata
- Authors
- Kang, S., Narazaki, M., Metwally, H., & Kishimoto, T.
- Affiliations
- Immunology Frontier Research Center, The University of Osaka (JP)
- The University of Osaka (JP)
- Corresponding author
- Kishimoto, Tadamitsu
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2020-04-08
- Volume
- 217
- Issue
- 5
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC7201933
- OpenAlex
- W3014527183
- Cited by
- 360
- References
- 105
- Citations by year
- 2026: 25 · 2025: 96 · 2024: 76 · 2023: 72 · 2022: 49 · 2021: 33 · 2020: 9
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-04-27)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology (17K15722, 17K10002)
- Astellas Foundation for Research on Metabolic Disorders
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- interleukin-6, IL-6 family cytokines, gp130, IL-6 receptor, IL-6 signaling, IL-6 inhibitors, B cell antibody production
- MeSH terms
- Animals, Humans, Models, Biological, Mutation, Interleukin-6, Receptors, Interleukin-6, MicroRNAs, History, 20th Century, Genetic Pleiotropy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.